Apollo Care, Llc: Semaglutide 2.25mg (0.9 Mg/ml), 2
Recall Summary Apollo Care, LLC is recalling Semaglutide 2.25mg injection vials nationwide because they contain visible particles made of nylon and silk-like material. The recalled product was distributed across all U.S. states and Washington, D.C. This is a Class II recall, meaning use of the product could cause serious adverse health effects.
- Recalling firm
- Apollo Care, LLC
- Product
- SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02
- Reason
- Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-29
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the U.S
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/3ed1d392-2c62-47df-b28f-1e93084038bc